Patents by Inventor Larry Anthony

Larry Anthony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8257957
    Abstract: The present invention provides genetically modified host cells and use of same for producing isoprenoid compounds.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: September 4, 2012
    Assignees: The Regents of the University of California, Amyris Biotechnologies, Inc.
    Inventors: Jay D. Keasling, Farnaz Nowroozi, Douglas J. Pitera, Jennifer Anthony, Jack D. Newman, Larry Anthony
  • Publication number: 20100178679
    Abstract: The present invention provides methods for a robust production of isoprenoids utilizing the DXP biosynthetic path-way. The invention also provides nucleic acids, enzymes, expression vectors, and genetically modified host cells for carrying out the subject methods.
    Type: Application
    Filed: April 14, 2008
    Publication date: July 15, 2010
    Inventors: Larry Anthony, Jack Newman
  • Publication number: 20100112672
    Abstract: The present invention provides genetically modified host cells and use of same for producing isoprenoid compounds.
    Type: Application
    Filed: September 25, 2007
    Publication date: May 6, 2010
    Inventors: Jay D. Keasling, Farnaz Nowroozi, Douglas J. Pitera, Jack D. Newman, Jennifer Anthony, Larry Anthony
  • Publication number: 20060003454
    Abstract: The present invention relates to compositions comprising conjugation-competent non-dividing cells for delivery of genes to bacterial cells by conjugation. The present invention also relates to methods of making, using, and storing such conjugation competent non-dividing cells.
    Type: Application
    Filed: July 2, 2004
    Publication date: January 5, 2006
    Applicant: ConjuGon, Inc.
    Inventors: Hideki Suzuki, Marcin Filutowicz, Larry Anthony
  • Publication number: 20050181395
    Abstract: The present invention relates to bacterial expression vectors. In particular, the present invention provides tightly-regulated bacterial expression vectors designed for the cloning and expression of toxic proteins, RNA, and metabolites in vivo. The present invention thus provides methods of expressing protein and RNAs that were previously not able to be expressed.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 18, 2005
    Applicant: ConjuGon, Inc.
    Inventors: Larry Anthony, Marcin Filutowicz, Hideki Suzuki
  • Patent number: D259639
    Type: Grant
    Filed: September 5, 1978
    Date of Patent: June 23, 1981
    Assignee: Rolm Corporation
    Inventors: Larry Anthony, Wayne Kasom, Jr.